News

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...
The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...
Health and Human Services Secretary Robert F. Kennedy Jr. on Tuesday announced the removal of the COVID-19 vaccine from the ...